PARP11: A Multifunctional PARP Family Member Shaping Transcription, Cell Cycle, and Disease

PARP11: A Multifunctional PARP Family Member Shaping Transcription, Cell Cycle, and Disease—Supported by ANT BIO PTE. LTD.
 

1. Concept
PARP11 (Poly(ADP-ribose) polymerase 11) is a unique member of the PARP family, distinct from well-known homologs like PARP1 and PARP2. It mediates cellular regulation primarily through ADP-ribosylation—transferring ADP-ribose from NAD+ to target proteins—and molecular interactions, functioning across the nucleus, cytoplasm, and cell membrane.

Structurally, PARP11 features a conserved catalytic domain for ADP-ribosylation, with unique N- and C-terminal regions that distinguish its functions from other PARPs. Unlike PARP1, it is not rapidly activated by DNA damage but instead regulates diverse processes including transcriptional activity, cell cycle progression, RNA metabolism, and cellular stress responses. Its ability to target specific proteins (e.g., transcription factors, cell cycle regulators) makes it a key modulator of intracellular signaling networks.

2. Research Frontiers
PARP11 research is advancing across transcriptional regulation, cell cycle control, and disease biology. A key frontier is deciphering its substrate specificity and ADP-ribosylation mechanisms, with mass spectrometry and structural biology revealing novel interaction partners. In cancer research, studies explore how abnormal PARP11 expression contributes to tumorigenesis, with potential as a therapeutic target.

In neurodegenerative diseases, research focuses on PARP11’s role in oxidative stress and DNA damage repair, investigating its potential to mitigate disease progression. Immunology studies uncover its influence on immune cell function and inflammatory responses, opening avenues for autoimmune and infectious disease therapies. Future directions include developing PARP11-specific modulators (inhibitors/activators) and using single-cell technologies to map cell-type-specific functions.

3. Research Significance
PARP11’s significance lies in its multifaceted role as a regulator of core cellular processes. It modulates transcription, cell cycle, and stress responses, providing insights into normal physiology and disease pathogenesis. In cancer, its dysregulation links to genomic instability and malignancy, offering a new therapeutic target.

In neurodegenerative diseases, its role in damage repair and stress responses suggests potential neuroprotective applications. Basic research clarifies PARP family diversity, while translational efforts advance precision medicine—addressing unmet needs in cancer, neurological disorders, and immune-related diseases.

4. Biological Functions, Disease Roles, and Product Support
4.1 Core Biological Functions
4.1.1 Transcriptional Regulation
• PARP11 ADP-ribosylates transcription factors (e.g., NF-κB, AP-1) and RNA polymerase II, modulating their activity and recruitment to target genes.
• Activated during cellular stress (oxidative stress, infection) to alter transcriptional profiles, promoting stress adaptation and repair.
• Participates in RNA splicing and transcriptional activation, influencing gene expression networks.

4.1.2 Cell Cycle Regulation
• Regulates stability and function of cell cycle proteins (Cyclin D, p53, CDK complexes) via ADP-ribosylation.
• Modulates p53 transcriptional activity, influencing G1/S checkpoint control and apoptosis in response to DNA damage.
• Ensures orderly cell cycle progression by fine-tuning CDK complex activity, supporting normal cell proliferation and division.

4.1.3 Cellular Stress Responses
• Activates oxidative stress-related transcription factors (NF-κB, AP-1) to induce protective gene expression.
• Regulates DNA damage repair proteins (PARP1, XRCC1) to enhance damage resolution.
• Contributes to cellular adaptation to environmental pressures (heat stress, oxidative stress) by adjusting signaling and transcriptional programs.

4.2 Disease Roles of PARP11
• Cancer: Abnormal PARP11 expression correlates with tumor malignancy, potentially driving genomic instability and drug resistance. It regulates cancer cell proliferation, metastasis, and stress adaptation, making it a promising therapeutic target.
• Neurodegenerative Diseases: Dysregulation in Alzheimer’s/Parkinson’s disease models links to impaired stress responses and DNA repair; modulating PARP11 may slow disease progression.
• Immune-Related Diseases: Influences immune cell function and inflammatory responses, with potential roles in autoimmune diseases and infection outcomes.

4.3 How ANT BIO PTE. LTD. Supports PARP11 Research
ANT BIO PTE. LTD., through its sub-brand UA (specializing in recombinant proteins), provides a high-quality PARP11 protein to advance mechanistic and translational research.

Key product and applications:
UA080022 (PARP11, GST&His Tag Protein, Human): Baculovirus-Insect Cells-expressed human PARP11 with GST and His tags. Ideal for:
• Studying ADP-ribosylation activity and substrate interactions.
• Screening PARP11-specific modulators (inhibitors/activators).
• Structural biology studies and immunoprecipitation assays.
• Validating PARP11’s role in transcriptional regulation and cell cycle control.

Rigorous quality control ensures high purity, biological activity, and consistency—critical for reproducible experiments in drug discovery and basic research.

5. Brand Mission
ANT BIO PTE. LTD. is dedicated to empowering the global life science community with high-quality, innovative biological reagents and solutions. With 15 years of antibody development experience, the company leverages advanced platforms—including recombinant antibody development (rabbit/mouse monoclonal), recombinant protein expression systems (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA, and PTM Pan-Modification Antibody platforms—to deliver a comprehensive product portfolio.

Through its three specialized sub-brands—Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins)—ANT BIO PTE. LTD. adheres to international certifications (EU 98/79/EC, ISO9001, ISO13485) and strict quality standards. The company’s mission is to accelerate scientific discovery by providing tools that enhance experimental precision, efficiency, and reproducibility. ANT BIO PTE. LTD. is committed to supporting PARP11 research and global efforts in cancer therapy, neurodegenerative disease treatment, and immunology, ultimately advancing human health through interdisciplinary collaboration and innovation.

6. Related Product List

Product Code	Product Name	Product Details
UA080022	PARP11, GST&His Tag Protein	Host: Human; Expression System: Baculovirus-Insect Cells; Conjugation: Unconjugated

7. AI Disclaimer
This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.
 
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.